Injectable Drug Delivery Market

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021

Report Code: MD 3680 Feb, 2017, by marketsandmarkets.com

MarketsandMarkets forecasts the injectable drug delivery market to grow from USD 362.4 billion in 2016 to USD 624.5 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period. The major factors responsible for the growth of this market are the increasing use of biologics, increase in the prevalence of chronic diseases, increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors have increased the demand for devices such as safety syringes, prefilled syringes, and autoinjectors.

The objective of the report is to define, describe, and forecast the injectable drug delivery market size based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and region.

Injectable Drug Delivery Market

By type, the formulation segment to witness the highest growth during the forecast period (2016–2021).

Based on type, the injectable drug delivery market is further segmented into formulation, and devices. The formulation segment is expected to grow at the highest CAGR during the forecast period. The high growth of this market segment is attributed to the growing prevalence of chronic diseases, patient adherence, and the rising adoption of self-injection, new technologies, and biologics.

By facility of use, the hospitals and clinics segment to dominate during the forecast period

The hospitals and clinics segment are expected to dominate the market. The large share of this segment is attributed to the rising prevalence of chronic diseases, patient compliance, and technological advancements.

Injectable Drug Delivery Market

North America to account for the largest market size during the forecast period.

North America is expected to hold the largest market size in autoinjector market during the forecast period, followed by the European region. Factors such as the increasing incidence of chronic diseases, growth of biologicd market, and increasing demand of self-injection devices.

Asia is the third-largest market for Needle-free injector market. This market is poised to witness the highest growth due to the increasing prevalence of chronic diseases, rise in disposable income, growing awareness on safety and comfort, and increasing number of partnerships in this market space.

Market Dynamics

Driver: Growth in biologics market

According to the American Journal of Managed Health Care, biologics form the fastest-growing segment in the pharmaceutical market. An article published by PHARMAC stated that between 2007 and 2012, the global spending on all medicines increased by 24%; in the same period, the spending on biologics increased by 367%.

According to an article published by The Economist, in the U.S., more than 900 biologics are under development for the treatment of more than 100 diseases. It is estimated that approximately USD 170 billion is spent on biologics globally, and this figure is expected to grow to approximately USD 220 billion by 2017. A major factor responsible for this trend is the rising demand for vaccines, insulin, human growth hormone, and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years.

Biologics currently account for approximately 70% of the top-10 selling drugs in the world (Source: BioPharm International). Considering the significant demand for and potential of biologics, market players are focusing on undertaking strategic developments to leverage the growth opportunities in this market segment.

A key product in the injectable drug delivery market is Humira (AbbVie Inc.), which is used for the treatment of moderate to severe rheumatoid arthritis (RA). Enbrel (Pfizer) is a prescription medicine that can be self-injected and is used for the treatment of long-term inflammatory diseases. Herceptin (Roche) is a subcutaneous injection used for the treatment of cancer.

Restraint: Product recall

In recent years, there have been numerous product recalls in the injectable drug delivery technology market. Recalls can be voluntary or can result after the intervention of regulatory authorities. Usability issues must be identified and addressed during the development process. The presence of visible foreign matter during the testing of retention samples in injectables can cause severe health consequences such as permanent impairment of a body function, damage and/or obstruction of blood vessels, local inflammation, phlebitis, allergic response and/or embolization in the body, and infection. Other reasons due to which injectables face recalls are contamination from inorganic materials such as glass, silicone, and stainless steel, and also due to incomplete filling of vials.

If a product is recalled, the process of retrieving and replacing the defective product may cause a company or a manufacturer to incur huge losses associated with the replacement and fixing of faulty products. These huge losses will affect the revenue and the share of the company in the market, which in turn will impact the overall market.

Opportunity: Contraceptive injectable

Over the years, the use of injectable contraceptives has increased significantly. This increased use of injectable contraceptives can mainly be attributed to their high efficacy. Injectable contraceptives are not required to be taken daily; they can be administered once every month or once every three months and are considered to be one of the safer modes of pregnancy prevention. They prevent pregnancy 99% of the time, when administered correctly. Due to these reasons the demand for contraceptive injectables is expected to drive the market in future.

According to Guttmacher Institute, in 2012, around 1,697,000 women used injectables for contraception in the U.S. Noristerat Injection is a reversible method of prescription birth control, which is common in the U.K. and other parts of Europe.

Many new products are being launched in contraceptive injections. For instance; in September 2015, Pfizer Inc. launched Sayana Press, the first injectable contraceptive in the U.K. for administration by self-injection.

Challenge: Contraceptive injectable Preference for other mode of drug delivery

The injectable mode of drug delivery offers a large surface area for absorption as a result of which it achieves rapid systemic levels of absorption. However, the use of injectables can lead to needlestick injuries and infections, needle phobia, anxiety, and pain. All these factors limit the market for injectables to a certain extent. Among the various routes of drug delivery, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable.

Inhalation facilitates rapid absorption due to the huge surface area of the respiratory endothelium; bronchodilators and inhaled steroids can be targeted at the lungs with low levels of systemic absorption. The topical route of drug administration is considered better than injections as drugs are applied directly to the skin and it is non-invasive, easy, and there is a high level of patient compliance.

This preference for other routes of drug administration is a major challenge for the injectable drug delivery technology market.

Scope of the Report

Report Metric

Details

Market size available for years

2014–2021

Base year considered

2015

Forecast period

2016–2021

Forecast units

Billion (USD)

Segments covered

Type (Devices, and Formulations), packaging formulations (Ampoules, Vials, Cartridges, and bottles), therapeutic application (autoimmune diseases, hormonal disorders, orphan diseases, cancer, other therapeutic application) usage patter (curative care, immunization, and other), site of administration (skin, circulatory/musculoskeletal system, organs, central nervous system), distribution channel (hospital, and retail pharmacy stores), facility of use (hospitals and clinics, home care settings, other facility of use) and region

Geographies covered

North America, Europe, Asia, and Rest of the World

Companies covered

Becton, Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland), and B. Braun Melsungen (Germany).

The research report categorizes the injectable drug delivery market to forecast the revenues and analyze the trends in each of the following sub-segments:

Injectable Drug Delivery Market

Injectable Drug Delivery Market, by Type

  • Devices
  • Formulations

Injectable Drug Delivery Market, by Formulation Packaging

  • Ampules
  • Vials
  • Cartridges
  • Bottles

Injectable Drug Delivery Market, by Therapeutic Application

  • Auto-immune diseases
  • Hormonal Disorders
  • Orphan Diseases
  • Oncology
  • Other Therapeutic Applications

Injectable Drug Delivery Market, by Usage Pattern

  • Curative Care
  • Immunization
  • Other Usage Pattern

Injectable Drug Delivery Market, by Site of Administration

  • Skin
  • Circulatory/Musculoskeletal
  • Organs
  • Central Nervous System

Injectable Drug Delivery Market, by Distribution Channel

  • Hospitals
  • Retail Pharmacy Stores

Injectable Drug Delivery Market, by Facility of Use

  • Hospitals & Clinics
  • Home Care Settings
  • Other Facilities of Use

Injectable Drug Delivery Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K
    • Rest of Europe (RoE)
  • Asia
    • China
    • India
    • Japan
    • Rest of Asia (RoA)
  • Rest of the World (RoW)

Key Market Players

Prominent players in the injectable drug delivery market are Becton, Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Sandoz (Germany), Terumo (Japan), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland), Bespak (U.K.), and B. Braun Melsungen (Germany).

Becton, Dickinson and Company (U.S.) led the injectable drug delivery market in 2015. The company offers an exclusive product portfolio comprising a variety of pen injectors, autoinjectors, autodisable injection systems, and conventional injections and syringes. It focuses on both organic as well as inorganic growth strategies to maintain its leading position in the market. For instance, in March 2015, BD acquired CareFusion Corp. (U.S.) to expand its offerings and provide better medication management and patient safety solutions. In the same year, BD acquired CRISI Medical Systems (U.S.), a company that operates in medical technology, to increase the efficiency of drug delivery through IV injectables. BD has its presence in 50 countries across the globe, which enables it to maintain its position in global market.

Recent Developments

  • In 2016, Gerresheimer extended its partnership with Taisei Medical Co. Ltd. (Japan) with an aim to market its ClearJect syringes and provide technical support to its customers. Furthermore, in collaboration with Taisei Medical, the company intends to expand its COP syringe portfolio by manufacturing a new Gx RTF ClearJect brand by combining ClearJect with its glass RTF (ready-to-fill) concept. This partnership is expected to help the company expand its product portfolio and customer base in the syringes market.
  • In 2015, Eli Lilly and Company and Sanford-Burnham Medical Research Institute (U.S.) entered into a collaboration for the development of immunological therapies focusing on lupus, Sjφgren's syndrome, inflammatory bowel disease, and other autoimmune disorders. This collaboration will combine the expertise of both organizations to develop novel treatments for these diseases.
  • In 2014, Terumo Corporation collaborated with Ypsomed Group (a Switzerland-based injection systems manufacturer). Through this collaboration, the company integrated its prefillable polymer syringe, namely, PLAJEX with YpsoMate (an autoinjector system from Ypsomed). This helped the company strengthen its product offerings in the syringes market.

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the autoinjector market, and Needle-Free Injectors market market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 24)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 27)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Data From Secondary Sources
    2.4 Key Data From Primary Sources
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 34)

4 Premium Insights (Page No. - 37)
    4.1 Market Overview
    4.2 Injectable Drug Delivery Market, By Facility of Use
    4.3 Geographic Analysis: By Site of Administration
    4.4 Injectable Drug Delivery Market, By Formulation Packaging
    4.5 Geographical Snapshot

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Prevalence of Chronic Diseases
                    5.2.1.2 Increase in Demand for Self-Injection Devices
                    5.2.1.3 Growth in the Biologics Market
                    5.2.1.4 Technological Advancements and New Product Launches
           5.2.2 Restraints
                    5.2.2.1 Infections Associated With Needlestick Injuries
                    5.2.2.2 Product Recalls
           5.2.3 Opportunities
                    5.2.3.1 Increase in Demand for Biosimilar and Generic Injectables
                               5.2.3.1.1 Biosimilars
                               5.2.3.1.2 Generic Injectables
                    5.2.3.2 Contraceptive Injectables
           5.2.4 Challenge
                    5.2.4.1 Preference for Other Modes of Drug Delivery

6 Regulatory Scenario (Page No. - 49)
    6.1 Introduction
    6.2 FDA and CE Approvals
    6.3 The European Medicines Agency (EMA)
    6.4 Clinical Trials

7 Injectable Drug Delivery Market, By Type (Page No. - 51)
    7.1 Introduction
    7.2 Devices
           7.2.1 Conventional Injection Devices
                    7.2.1.1 By Material
                               7.2.1.1.1 Glass
                               7.2.1.1.2 Plastic
                    7.2.1.2 By Product
                               7.2.1.2.1 Fillable Syringes
                               7.2.1.2.2 Prefilled Syringes
                    7.2.1.3 By Usability
                               7.2.1.3.1 Reusable Injection Devices
                               7.2.1.3.2 Disposable Injection Devices
           7.2.2 Self-Injection Devices
                    7.2.2.1 Needle-Free Injectors
                               7.2.2.1.1 By Product
                                             7.2.2.1.1.1 Fillable Needle-Free Injectors
                                             7.2.2.1.1.2 Prefilled Needle-Free Injectors
                               7.2.2.1.2 By Technology
                                             7.2.2.1.2.1 Jet-Based Needle-Free Injectors
                                             7.2.2.1.2.2 Spring-Based Needle-Free Injectors
                                             7.2.2.1.2.3 Laser-Powered Needle-Free Injectors
                                             7.2.2.1.2.4 Vibration-Based Needle-Free Injectors
                               7.2.2.1.3 By Usability
                                             7.2.2.1.3.1 Reusable Needle-Free Injectors
                                             7.2.2.1.3.2 Disposable Needle-Free Injectors
                    7.2.2.2 Autoinjectors
                               7.2.2.2.1 By Product
                                             7.2.2.2.1.1 Fillable Autoinjectors
                                             7.2.2.2.1.2 Prefilled Autoinjectors
                               7.2.2.2.2 By Technology
                                             7.2.2.2.2.1 Automated Autoinjectors
                                             7.2.2.2.2.2 Manual Autoinjectors
                               7.2.2.2.3 By Design
                                             7.2.2.2.3.1 Standardized Autoinjectors
                                             7.2.2.2.3.2 Customized Autoinjectors
                               7.2.2.2.4 By Usability
                                             7.2.2.2.4.1 Reusable Autoinjectors
                                             7.2.2.2.4.2 Disposable Autoinjectors
                    7.2.2.3 Pen Injectors
                               7.2.2.3.1 By Product
                                             7.2.2.3.1.1 Single-Chambered Pen Injectors
                                             7.2.2.3.1.2 Dual-Chambered Pen Injectors
                               7.2.2.3.2 By Design
                                             7.2.2.3.2.1 Standard Pen Injectors
                                             7.2.2.3.2.2 Customized Pen Injectors
                               7.2.2.3.3 By Usability
                                             7.2.2.3.3.1 Reusable Pen Injectors
                                             7.2.2.3.3.2 Disposable Pen Injectors
                    7.2.2.4 Wearable Injectors
                    7.2.2.5 Other Devices
    7.3 Formulations
           7.3.1 Conventional Drug Delivery Formulations
                    7.3.1.1 Solutions
                    7.3.1.2 Reconstituted/Lyophilized Formulations
                    7.3.1.3 Suspensions
                    7.3.1.4 Emulsions
           7.3.2 Novel Drug Delivery Formulations
                    7.3.2.1 Colloidal Dispersions
                               7.3.2.1.1 Niosomes
                               7.3.2.1.2 Liposomes
                               7.3.2.1.3 Polymeric/Mixed Micelles
                               7.3.2.1.4 Nanoparticles
                                             7.3.2.1.4.1 Solid-Lipid Nanoparticles
                                             7.3.2.1.4.2 Nanosuspensions
                                             7.3.2.1.4.3 Nanoemulsions
                    7.3.2.2 Microparticles
                               7.3.2.2.1 Microspheres
                               7.3.2.2.2 Microcapsules
           7.3.3 Long-Acting Injection Formulations

8 Injectable Drug Delivery Market, By Formulation Packaging (Page No. - 100)
    8.1 Introduction
    8.2 Ampules
    8.3 Vials
    8.4 Cartridges
    8.5 Bottles

9 Injectable Drug Delivery Market, By Therapeutic Application (Page No. - 104)
    9.1 Introduction
    9.2 Autoimmune Diseases
           9.2.1 Rheumatoid Arthritis
           9.2.2 Multiple Sclerosis (MS)
           9.2.3 Crohn’s Disease
           9.2.4 Psoriasis
           9.2.5 Other Autoimmune Diseases
    9.3 Hormonal Disorders
           9.3.1 Diabetes
           9.3.2 Anemia
           9.3.3 Reproductive Health Disease
           9.3.4 Antithrombotic/Thrombolytic Therapy
           9.3.5 Osteoporosis
           9.3.6 Growth Hormone Deficiency (GHD)
    9.4 Orphan Diseases
    9.5 Cancer
    9.6 Other Therapeutic Applications
           9.6.1 Pain Management
           9.6.2 Allergies
           9.6.3 Aesthetic Treatment
           9.6.4 Hepatitis C
           9.6.5 Hemophilia

10 Injectable Drug Delivery Market, By Usage Pattern (Page No. - 125)
     10.1 Introduction
     10.2 Curative Care
     10.3 Immunization
     10.4 Others

11 Injectable Drug Delivery Market, By Site of Administration (Page No. - 130)
     11.1 Introduction
     11.2 Skin (Intradermal and Subcutaneous)
     11.3 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
     11.4 Organs (Intravitreal and Intra-Articular)
     11.5 Central Nervous System (Intracerebral and Intrathecal)

12 Injectable Drug Delivery Market, By Distribution Channel (Page No. - 136)
     12.1 Introduction
     12.2 Hospitals
     12.3 Retail Pharmacy Stores

13 Injectable Drug Delivery Market, By Facility of Use (Page No. - 139)
     13.1 Introduction
     13.2 Hospitals and Clinics
     13.3 Home Care Settings
     13.4 Other Facilities of Use

14 Injectable Drug Delivery Market, By Region (Page No. - 144)
     14.1 Introduction
     14.2 North America
             14.2.1 U.S.
             14.2.2 Canada
     14.3 Europe
             14.3.1 Germany
             14.3.2 France
             14.3.3 U.K.
             14.3.4 Italy
             14.3.5 Spain
             14.3.6 Rest of Europe (RoE)
     14.4 Asia
             14.4.1 China
             14.4.2 Japan
             14.4.3 India
             14.4.4 Rest of Asia
     14.5 Rest of the World (RoW)

15 Competitive Landscape (Page No. - 215)
     15.1 Overview
     15.2 Market Share Analysis
     15.3 Competitive Situation and Trends
             15.3.1 Partnerships, Agreements, and Collaborations
             15.3.2 Product Launches, Approvals, and Enhancements
             15.3.3 Expansions
             15.3.4 Acquisitions

16 Company Profiles (Page No. - 221)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     16.1 Introduction
     16.2 Baxter International, Inc.
     16.3 Becton, Dickinson and Company
     16.4 Gerresheimer AG
     16.5 Pfizer, Inc.
     16.6 Schott AG
     16.7 ELI Lilly and Company
     16.8 Sandoz (A Division of Novartis AG)
     16.9 Terumo Corporation
     16.10 Teva Pharmaceutical Industries Ltd.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

17 Appendix (Page No. - 245)
     17.1 Insights From Industry Experts
     17.2 Discussion Guide
     17.3 Other Recent Developments
     17.4 Available Customizations
     17.5 Knowledge Store: Marketsandmarkets’ Subscription Portal
     17.6 RT: Real-Time Market Intelligence
     17.7 Related Reports
     17.8 Author Details


List of Tables (288 Tables)

Table 1 Product Recalls (2013–2015)
Table 2 Injectable Drugs Going Off-Patent in the U.S.
Table 3 List of Regulatory Authorities in Major Countries
Table 4 List of FDA Approved in the Market (2015-2016)
Table 5 Injectable Drugs in Phase Iii Clinical Trials
Table 6 Product Recalls (2015-2016)
Table 7 Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 8 Injectable Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 9 Injectable Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 10 Conventional Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 11 Conventional Injection Devices Market Size, By Material, 2014–2021 (USD Billion)
Table 12 Conventional Glass Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 13 Conventional Plastic Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 14 Conventional Injection Devices Market Size, By Product, 2014–2021 (USD Billion)
Table 15 Conventional Fillable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 16 Conventional Prefilled Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 17 Conventional Injection Devices Market Size, By Usability, 2014–2021 (USD Billion)
Table 18 Conventional Reusable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 19 Conventional Disposable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 20 Self-Injection Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 21 Self-Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 22 Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 23 Needle-Free Injectors Market Size, By Product, 2014–2021 (USD Billion)
Table 24 Fillable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 25 Prefilled Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 26 Needle-Free Injectors Market Size, By Technology, 2014–2021 (USD Million)
Table 27 List of Some of the Needle-Free Jet Injectors Available in the Market
Table 28 Jet-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 29 List of Some of the Needle-Free Spring-Based Injectors Available in the Market
Table 30 Spring-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 31 Laser-Powered Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 32 Vibration-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 33 Needle-Free Injectors Market Size, By Usability, 2014–2021 (USD Billion)
Table 34 Reusable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 35 Disposable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 36 Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 37 Autoinjectors Market Size, By Product, 2014–2021 (USD Billion)
Table 38 Fillable Autoinjectors Market Size, By Region, 2014–2021 (USD Million)
Table 39 Prefilled Autoinjectors Market Size, By Region, 2014–2021 (USD Million)
Table 40 Autoinjectors Market Size, By Technology, 2014–2021 (USD Billion)
Table 41 Automated Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 42 Manual Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 43 Autoinjectors Market Size, By Design, 2014–2021 (USD Billion)
Table 44 Standardized Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 45 Customized Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 46 Autoinjector Market Size, By Usability, 2014–2021 (USD Billion)
Table 47 Reusable Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 48 Disposable Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 49 Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 50 Commercially Available Pen Injectors
Table 51 Pen Injectors Market Size, By Product, 2014–2021 (USD Billion)
Table 52 Single-Chambered Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 53 Commercially Available Dual-Chambered Pen Injectors
Table 54 Dual-Chambered Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 55 Pen Injectors Market Size, By Design, 2014–2021 (USD Billion)
Table 56 Standard Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 57 Customized Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 58 Pen Injectors Market Size, By Usability, 2014–2021 (USD Billion)
Table 59 Reusable Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 60 Disposable Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 61 Wearable Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 62 Other Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 63 Injectable Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 64 Injectable Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 65 Conventional Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 66 Conventional Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 67 Solutions Market Size, By Region, 2014–2021 (USD Billion)
Table 68 Reconstituted/Lyophilized Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 69 Suspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 70 Emulsions Market Size, By Region, 2014–2021 (USD Billion)
Table 71 Novel Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 72 Novel Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 73 Colloidal Dispersions Market Size, By Type, 2014–2021 (USD Billion)
Table 74 Colloidal Dispersions Market Size, By Region, 2014–2021 (USD Billion)
Table 75 Niosomes Market Size, By Region, 2014–2021 (USD Billion)
Table 76 Liposomes Market Size, By Region, 2014–2021 (USD Billion)
Table 77 Polymeric/Mixed Micelles Market Size, By Region, 2014–2021 (USD Billion)
Table 78 Nanoparticles Market Size, By Type, 2014–2021 (USD Billion)
Table 79 Nanoparticles Market Size, By Region, 2014–2021 (USD Billion)
Table 80 Solid-Lipid Nanoparticles Market Size, By Region, 2014–2021 (USD Billion)
Table 81 Nanosuspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 82 Nanoemulsions Market Size, By Region, 2014–2021 (USD Million)
Table 83 Microparticles Market Size, By Type, 2014–2021 (USD Billion)
Table 84 Microparticles Market Size, By Region, 2014–2021 (USD Billion)
Table 85 Microspheres Market Size, By Region, 2014–2021 (USD Billion)
Table 86 Microcapsules Market Size, By Region, 2014–2021 (USD Billion)
Table 87 Long-Acting Injection Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 88 Injectable Drug Delivery Market Size, By Formulation Packaging, 2014–2021 (USD Billion)
Table 89 Injectable Drug Delivery Market Size for Formulation Packaging, By Region, 2014–2021 (USD Billion)
Table 90 Injectable Drug Delivery Market Size for Ampules, By Region, 2014–2021 (USD Billion)
Table 91 Injectable Drug Delivery Market Size for Vials, By Region, 2014–2021 (USD Billion)
Table 92 Injectable Drug Delivery Market Size for Cartridges, By Region, 2014–2021 (USD Billion)
Table 93 Injectable Drug Delivery Market Size for Bottles, By Region, 2014–2021 (USD Billion)
Table 94 Injectable Drug Delivery Market Size, By Therapeutic Application, 2014–2021 (USD Billion)
Table 95 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Indication, 2014–2021 (USD Billion)
Table 96 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Region, 2014–2021 (USD Billion)
Table 97 Injectable Drug Delivery Market Size for Rheumatoid Arthritis, By Region, 2014–2021 (USD Billion)
Table 98 Injectable Drug Delivery Market Size for Multiple Sclerosis, By Region, 2014–2021 (USD Billion)
Table 99 Market Size for Crohn’s Disease, By Region, 2014–2021 (USD Billion)
Table 100 Injectable Drug Delivery Market Size for Psoriasis, By Region, 2014–2021 (USD Billion)
Table 101 Market Size for Other Autoimmune Diseases, By Region, 2014–2021 (USD Billion)
Table 102 Injectable Drug Delivery Market Size for Hormonal Disorders, By Indication, 2014–2021 (USD Billion)
Table 103 Injectable Drug Delivery Market Size for Hormonal Disorders, By Region, 2014–2021 (USD Billion)
Table 104 Market Size for Diabetes, By Region, 2014–2021 (USD Billion)
Table 105 Injectable Drug Delivery Market Size for Anemia, By Region, 2014–2021 (USD Billion)
Table 106 Injectable Drug Delivery Market Size for Reproductive Health Disease, By Region, 2014–2021 (USD Billion)
Table 107 Market Size for Antithrombotic/Thrombolytic Therapy, By Region, 2014–2021 (USD Billion)
Table 108 Injectable Drug Delivery Market Size for Osteoporosis, By Region, 2014-2021 (USD Billion)
Table 109 Injectable Drug Delivery Market Size for Growth Hormone Deficiency, By Region, 2014-2021 (USD Billion)
Table 110 Injectable Drug Delivery Market Size for Orphan Diseases, By Region, 2014-2021 (USD Billion)
Table 111 Market Size for Cancer, By Region, 2014-2021 (USD Billion)
Table 112 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Indication, 2014-2021 (USD Billion)
Table 113 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Region, 2014-2021 (USD Billion)
Table 114 Injectable Drug Delivery Market Size for Pain Management, By Region, 2014-2021 (USD Billion)
Table 115 Market Size for Allergies, By Region, 2014-2021 (USD Billion)
Table 116 Injectable Drug Delivery Market Size for Aesthetic Treatments, By Region, 2014-2021 (USD Million)
Table 117 Injectable Drug Delivery Market Size for Hepatitis C, By Region, 2014-2021 (USD Billion)
Table 118 Injectable Drug Delivery Market Size for Hemophilia, By Region, 2014-2021 (USD Million)
Table 119 Injectable Drug Delivery Market Size, By Usage Pattern, 2014–2021 (USD Billion)
Table 120 Pipeline Curative Care Drugs (2016-2020)
Table 121 Market Size for Curative Care, By Region, 2014–2021 (USD Billion)
Table 122 Injectable Drug Delivery Market Size for Immunization, By Region, 2014–2021 (USD Billion)
Table 123 Injectable Drug Delivery Market Size for Other Usage Patterns, By Region, 2014–2021 (USD Billion)
Table 124 Market Size, By Site of Administration, 2014–2021 (USD Billion)
Table 125 Market for Injectable Drug Delivery Through Skin, By Region, 2014–2021 (USD Billion)
Table 126 Market for Injectable Drug Delivery Through Circulatory/Musculoskeletal System, By Region, 2014–2021 (USD Billion)
Table 127 Market for Injectable Drug Delivery Through Organs, By Region, 2014–2021 (USD Billion)
Table 128 Market for Injectable Drug Delivery Through Central Nervous System, By Region, 2014–2021 (USD Billion)
Table 129 Injectable Drug Delivery Market Size, By Distribution Channel, 2014–2021 (USD Billion)
Table 130 Injectable Drug Delivery Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 131 Injectable Drug Delivery Market Size for Retail Pharmacy Stores, By Region, 2014–2021 (USD Million)
Table 132 Injectable Drug Delivery Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 133 Injectable Drug Delivery Market Size for Hospitals and Clinics, By Region, 2014–2021 (USD Billion)
Table 134 Market Size for Home Care Settings, By Region, 2014–2021 (USD Billion)
Table 135 Market Size for Other Facilities of Use, By Region, 2014–2021 (USD Billion)
Table 136 Injectable Drug Delivery Market Size, By Region, 2014-2021 (USD Billion)
Table 137 North America: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 138 North America: Market Size, By Type, 2014–2021 (USD Billion)
Table 139 North America: Market Size, By Device, 2014-2021 (USD Billion)
Table 140 North America: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 141 North America: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 142 North America: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 143 North America: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 144 North America: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 145 North America: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 146 North America: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 147 U.S.: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 148 U.S.: Market Size, By Device, 2014-2021 (USD Billion)
Table 149 U.S.: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 150 U.S.: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 151 U.S.: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 152 U.S.: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 153 U.S.: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 154 U.S.: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 155 U.S.: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 156 List of Injectables Launched in Canada (2014-2015)
Table 157 Canada: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 158 Canada: Market Size, By Device, 2014-2021 (USD Billion)
Table 159 Canada: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 160 Canada: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 161 Canada: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 162 Canada: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 163 Canada: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 164 Canada: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 165 Canada: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 166 Europe: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 167 Europe: Market Size, By Type, 2014-2021 (USD Billion)
Table 168 Europe: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Billion)
Table 169 Europe: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 170 Europe: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 171 Europe: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 172 Europe: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 173 Europe: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 174 Europe: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 175 Europe: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 176 Germany: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 177 Germany: Market Size, By Device, 2014-2021 (USD Billion)
Table 178 Germany: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 179 Germany: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 180 Germany: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 181 Germany: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 182 Germany: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 183 Germany: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 184 Germany: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 185 France: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 186 France: Market Size, By Device, 2014-2021 (USD Billion)
Table 187 France: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 188 France: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 189 France: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 190 France: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 191 France: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 192 France: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 193 France: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 194 U.K.: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 195 U.K.: Market Size, By Device, 2014-2021 (USD Billion)
Table 196 U.K.: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 197 U.K.: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 198 U.K.: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 199 U.K.: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 200 U.K.: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 201 U.K.: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 202 U.K.: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 203 Italy: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 204 Italy: Market Size, By Device, 2014-2021 (USD Million)
Table 205 Italy: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 206 Italy: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 207 Italy: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 208 Italy: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 209 Italy: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 210 Italy: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 211 Italy: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 212 Spain: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 213 Spain: Market Size, By Device, 2014-2021 (USD Million)
Table 214 Spain: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 215 Spain: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 216 Spain: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 217 Spain: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 218 Spain: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 219 Spain: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 220 Spain: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 221 RoE: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 222 RoE: Market Size, By Device, 2014-2021 (USD Billion)
Table 223 RoE: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 224 RoE: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 225 RoE: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 226 RoE: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 227 RoE: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 228 RoE: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 229 RoE: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 230 Asia: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 231 Asia: Market Size, By Type, 2014-2021 (USD Billion)
Table 232 Asia: Market Size, By Device, 2014-2021 (USD Billion)
Table 233 Asia: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 234 Asia: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 235 Asia: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 236 Asia: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 237 Asia: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 238 Asia: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 239 Asia: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 240 China: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 241 China: Market Size, By Device, 2014-2021 (USD Billion)
Table 242 China: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 243 China: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 244 China: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 245 China: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 246 China: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 247 China: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 248 China: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 249 Japan: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 250 Japan: Market Size, By Device, 2014-2021 (USD Billion)
Table 251 Japan: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 252 Japan: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 253 Japan: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 254 Japan: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 255 Japan: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 256 Japan: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 257 Japan: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 258 India: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 259 India: Market Size, By Device, 2014-2021 (USD Billion)
Table 260 India: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 261 India: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 262 India: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 263 India: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 264 India: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 265 India: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 266 India: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 267 RoA: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 268 RoA: Market Size, By Device, 2014-2021 (USD Million)
Table 269 RoA: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 270 RoA: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 271 RoA: Market Size, By Usage Pattern, 2014-2021 (USD Million)
Table 272 RoA: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 273 RoA: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 274 RoA: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 275 RoA: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 276 RoW: Market Size, By Type, 2014-2021 (USD Billion)
Table 277 RoW: Market Size, By Device, 2014-2021 (USD Billion)
Table 278 RoW: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 279 RoW: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 280 RoW: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 281 RoW: Market Size, By Site of Administration, 2014–2021 (USD Billion)
Table 282 RoW: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 283 RoW: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 284 RoW: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 285 Partnerships, Agreements, and Collaborations (2013–2016)
Table 286 Product Launches, Approvals, and Enhancements (2013–2016)
Table 287 Expansions (2013–2016)
Table 288 Acquisitions (2013–2016)

List of Figures (34 Figures)

Figure 1 Injectable Drug Delivery Market
Figure 2 Research Design
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company, Designation and Region
Figure 6 Data Triangulation Methodology
Figure 7 Injectable Drug Delivery Market Snapshot, By Formulation 2016 vs 2021 (USD Billion)
Figure 8 Injectable Drug Delivery Market, By Facility of Use 2016 vs 2021 (USD Billion)
Figure 9 Injectable Drug Delivery Market, By Therapeutic Application, 2016 vs 2021 (USD Billion)
Figure 10 Injectable Drug Delivery Market, By Region (2016-2021)
Figure 11 Increasing Use of Biologic Drugs and Rising Prevalence of Chronic Diseases to Drive Market Growth
Figure 12 Hospitals and Clinics to Dominate the Market in 2016
Figure 13 Skin Segment to Command the Largest Market Share in 2016
Figure 14 Ampules to Dominate the Injectable Drug Delivery Market, in 2016
Figure 15 China to Register Highest Growth Rate During the Forecast Period
Figure 16 Market Drivers, Restraints, Opportunities, and Challenges
Figure 17 North America: Market Snapshot
Figure 18 Europe: Market Snapshot
Figure 19 Asia: Market Snapshot
Figure 20 Rest of the World: Market Snapshot
Figure 21 Key Players Adopted Inorganic Growth Strategies Between 2013 and 2016
Figure 22 Market Evolution Framework, 2013–2016
Figure 23 Global Market Share Analysis, 2015
Figure 24 Battle for Market Share: Partnerships, Agreements, and Collaborations are the Key Strategies Adopted By Market Players
Figure 25 Geographic Benchmarking of Top 5 Players
Figure 26 Baxter International, Inc.: Company Snapshot (2015)
Figure 27 Becton, Dickinson and Company: Company Snapshot (2015)
Figure 28 Gerresheimer AG: Company Snapshot (2015)
Figure 29 Pfizer, Inc.: Company Snapshot (2015)
Figure 30 Schott AG: Company Snapshot (2015)
Figure 31 ELI Lilly and Company: Company Snapshot (2015)
Figure 32 Sandoz: Company Snapshot (2015)
Figure 33 Terumo Corporation: Company Snapshot (2015)
Figure 34 Teva Pharmaceutical Industries Ltd.: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3680
Published ON
Feb, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Injectable Drug Delivery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home